Sensyne announces new independent non-executive director

Clinical AI company Sensyne Health plc has announced the appointment of Dr Ian Hudson as an independent non-executive director with effect from 28 June 2021. Hudson has worked extensively in the healthcare and pharmaceutical sector, having served as chief executive of the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) between 2013 and 2019. Prior…

You must be a HM Subscriber to view this content.

Subscribe Now »